Nextcure to present at the 19th annual morgan stanley global healthcare conference

Beltsville, md., sept. 02, 2021 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in a fireside chat at the 19th annual morgan stanley global healthcare conference on september 9th at 12:30 pm eastern time.
NXTC Ratings Summary
NXTC Quant Ranking